Our expertise
CORXEL is developing best-in-class treatments for cardiometabolic diseases.
The CORXEL advantage
Global biotech
A differentiated biotech with a patient-centric approach dedicated to improving outcomes in cardiometabolic diseases
Read more
Strong pipeline
A growing pipeline of high-quality assets with significant market potential globally.
Read more
Strategic partners
Founded by US-based RTW Investments and backed by global healthcare leader Bayer.
Read more
World class team
A world-class team with diversified background in multinational and domestic public companies and strong capabilities in clinical execution, regulatory and commercialization
Read more
